Clinical Trials Logo

Clinical Trial Summary

Background: ß-lactam (BL) antibiotics represent the main cause of allergic reactions to drugs, inducing both immediate and non-immediate reactions. The diagnosis is well established, usually based upon skin tests and drug provocation tests, but cumbersome.

Objectives: To design predictive models for the diagnosis of BL allergy, based on the clinical history of patients with suspicions of allergic reactions to BL.

Methods: The study included a retrospective phase in which records of patients consulting and explored for a suspicion of BL allergy (in the Allergy Unit of the University Hospital of Montpellier between September 1996 and September 2012) where used to construct predictive models; a prospective phase, in which we performed an external validation of the chosen models, in patients with suspicion of BL allergy recruited from 3 allergy centres (Montpellier, Nîmes, Narbonne), between March and November 2013. Data related to clinical history and allergy work-up results were retrieved and analysed. Logistic regression and decision tree method were used to design two models to predict the diagnosis of allergy to BL.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03076749
Study type Observational
Source University Hospital, Montpellier
Contact
Status Completed
Phase N/A
Start date February 2013
Completion date October 2014

See also
  Status Clinical Trial Phase
Completed NCT02839551 - Optimal Doses for Drug Provocation Tests to Beta-lactams N/A
Completed NCT00198419 - Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) Phase 1
Completed NCT02839811 - Medical Device for Drug Allergy Diagnosis N/A
Completed NCT02983630 - Allergy Testing of Patients Labeled as Penicillin Allergic N/A
Completed NCT00198458 - Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) Phase 1
Recruiting NCT04330118 - Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome
Completed NCT04421638 - Cephalosporin Hypersensitivity
Recruiting NCT02031120 - Management of Drug Hypersensitivity in Children N/A
Completed NCT01276314 - Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions N/A
Terminated NCT00505648 - Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin) Phase 3
Completed NCT03158831 - Drug Challenges Without Prior Skin Testing Phase 1
Active, not recruiting NCT06428162 - a Cross-sectional Study of Pharmacovigilance Practices Adherence Between Healthcare Providers in North African Nation
Terminated NCT02844712 - Negative Predictive Value of Drug Provocation Tests to Beta-lactams N/A
Completed NCT03743220 - Drug Provocation Test (DPT) to Non Steroidal Anti-inflammatory Drugs (NSAID)
Completed NCT03771118 - Drug Provocation Test (DPT) to Paracetamol
Not yet recruiting NCT06406114 - Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing Phase 2
Completed NCT05269082 - A Study to Assess the Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood of Children, Teenagers and Adults
Completed NCT04827602 - Drug Allergy Labels After Drug Allergy Investigation